Delivery Order SPE2DB22D3004-SPE2DB25FPU60
Award Date
3/6/25
Potential Completion Date
3/27/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) for the delivery of Zeposia 0.92 mg capsules. The fixed-price delivery order, valued at $13,399.71, has a completion date of January 11, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,399.71 Firm Fixed Price Delivery Order is for the supply of Zeposia 0.92 mg capsules, with a completion date of June 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,620.93 firm fixed-price delivery order is for the supply of Zeposia 0.92 mg capsules, a specialty medication. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Zeposia 0.92 mg capsules to the Defense Logistics Agency (DLA). The $13,862.79 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024. The contract has an ultimate completion date of December 12, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Zeposia 0.92 MG Capsule 30S. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and a completion date of July 22, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a single-award Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Zeposia 0.92 mg capsules, valued at $8,933.14. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUF85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,620.93 firm-fixed-price delivery order is for the drug Zeposia 0.92 mg capsule 30s. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,799.42, is for the delivery of Zeposia 0.92 MG Capsule 30S, a specialty medication. The award has a completion date of November 26, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...